• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Spate of Deal News Juices Start of This Week's Trading

We've become accustomed lately to gap-up opens on Mondays, but some fresh acquisition agreements are helping drive this Monday's action.
By JAMES "REV SHARK" DEPORRE
Sep 14, 2020 | 08:28 AM EDT
Stocks quotes in this article: ORCL, GILD, IMMU, MRK, SGEN, NVDA

A gap-up open on Monday morning has been the norm for a while, but the one this Monday morning comes with some very interesting acquisition-related news flow.

Oracle (ORCL) is cutting a deal to acquire TikTok, Gilead Sciences (GILD) is acquiring Immunomedics (IMMU) at a substantial premium, Merck (MRK) is taking a $1 billion stake in Seattle Genetics (SGEN) , and Nvidia (NVDA) is acquiring chipmaker Arm from Softbank.

This sort of deal activity appears to indicate that maybe valuations are not as outrageous as many of the market skeptics have been telling us. The action in the big-cap technology names has been disconnected from the broad market for quite some time and there have been concerns that the group could correct without also killing the broader market.

Although there is a perception that much of the market is very extended due to the strong action in the FATMAAN names it just isn't true. Only around 43% of stocks are trading above their 200-day simple moving averages (SMAs). They have bounced off the March lows but they have not run as fast or as high as the Nasdaq 100, which is still about 12% over its 200-day SMA even after the recent corrective action.

A good example of the disconnect is the action in biotechnology. The sector topped on July 20 and has been drifting lower for almost six weeks. This is obviously not the same sort of euphoric action that drove big-cap technology. The fact that there are some big deals in the sector here on Monday affirms that this group is in a much different position than the big-cap technology stocks.

Biotechnology is not the only group that is uncorrelated with the Nasdaq 100. Special purpose acquisition companies (SPACs) have been extremely hot lately and there is still plenty of good speculative action in individual stocks. The aggressive trading in lower-priced speculative junk has dried up and we aren't hearing as much about Robinhood traders, but there still are many active individual traders looking for action and they are providing some interesting movement.

The indices are in a somewhat precarious position technically as they deal with the 50-day SMA, but this is a tale of two markets. The FATMAAN names are coming back down to earth and looking for support while many other areas of the market are developing strong chart patterns and even attracting merger deals.

Don't focus too much on the indices or lose sight of the good stock picking that continues.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark had no positions in the stocks mentioned.

TAGS: Mergers and Acquisitions | Investing | Stocks | Biotechnology | Digital Entertainment | Healthcare | Pharmaceuticals | Semiconductors & Semiconductor Equipment | Technology | Real Money

More from Stocks

Market Looks Good from Above, Poor From Below

James "Rev Shark" DePorre
Jun 29, 2022 4:21 PM EDT

The major indexes held up well, but underneath, it wasn't pretty.

This FAANG Stock's Technicals Are at a Summer Crossroads

Bob Lang
Jun 29, 2022 3:30 PM EDT

Summer is a time when this name usually gains momentum. Will it this time?

Kass: Untapped Homeowners Equity and Imbedded Gains Will Be a Ballast to Growth

Doug Kass
Jun 29, 2022 3:00 PM EDT

Homeowners equity has more than tripled in the last decade.

Good High Yield Stocks Don't Have to Be Pricey. We've Got 3 to Prove It

Bob Ciura
Jun 29, 2022 1:32 PM EDT

Here are three cheap dividend stocks that should pay off big.

Don't Expect Fed Relief Anytime Soon

Maleeha Bengali
Jun 29, 2022 12:38 PM EDT

Major selloffs in recent years were accompanied by Fed cuts and market bottoms, but this time is different.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:51 PM EDT PAUL PRICE

    We should be in for better starting soon.

    Window dressing tomorrow, the last day of ...
  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login